The half-life of intravenous heparin is approximately 1.5 hours, with the whole-blood activated partial thromboplastin time identified as the most precise and economical assay for monitoring its effect.
Answers are grounded in this paper and cite their sources.
May inform weight-based heparin dosing and assay selection now; leaves open optimal monitoring strategies pending modern outcome trials.
The kinetics of heparin's anticoagulant activity were studied with four assay methods in human subjects, following single intravenous doses within the usual clinical dose range. The half-life of anticoagulant activity was about 1.5 hours. Minimum doses of heparin required to anticoagulate blood to a clinically desirable extent were about 35 units/kg. Of the four tests used, the whole-blood activated partial thromboplastin time provided the greatest precision, information, and economy, followed by, in order, the activated plasma partial thromboplastin time, the whole blood clotting time, and the partial thromboplastin time of plasma.
No takes yet. Share an insight, caveat, or question.
J. Worth Estes (1970) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: